Ameriprise’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Sell |
330,671
-347,910
| -51% | -$11.3M | ﹤0.01% | 1757 |
|
|
2025
Q1 | $25.6M | Sell |
678,581
-38,192
| -5% | -$1.44M | 0.01% | 1169 |
|
|
2024
Q4 | $58.7M | Buy |
716,773
+366,622
| +105% | +$30M | 0.02% | 758 |
|
|
2024
Q3 | $40M | Buy |
350,151
+72,387
| +26% | +$8.27M | 0.01% | 945 |
|
|
2024
Q2 | $21M | Buy |
277,764
+159,231
| +134% | +$12M | 0.01% | 1252 |
|
|
2024
Q1 | $8.1M | Buy |
118,533
+76,008
| +179% | +$5.19M | ﹤0.01% | 1984 |
|
|
2023
Q4 | $2.67M | Buy |
42,525
+30,846
| +264% | +$1.94M | ﹤0.01% | 2737 |
|
|
2023
Q3 | $595K | Buy |
+11,679
| New | +$595K | ﹤0.01% | 3338 |
|